Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
| Metric | Q4 2020 | Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | -15.60% | -78.42% | +102.47% |
| Gross Profit Growth | +0.00% | +0.00% | -15.60% | -78.42% | +102.47% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +19.38% | +30.85% | +33.43% | +19.75% | +16.34% |
| Weighted Average Shares Diluted Growth | +19.38% | +30.85% | +33.43% | +19.75% | +16.34% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -27.90% | +57.18% | -3.09% | -7.30% | -15.51% |
| Book Value per Share Growth | -64.88% | +63.14% | -26.60% | -32.08% | -55.52% |
| Debt Growth | +2.69% | +2.82% | +3.23% | +3.30% | +3.26% |
| R&D Expense Growth | +1.78% | +30.81% | +37.40% | +11.19% | +8.62% |
| SG&A Expenses Growth | +6.53% | -7.72% | +4.07% | -29.09% | -11.30% |